Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

EPZM:US

19.1000 USD 0.1000 0.53%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Epizyme Inc (EPZM)

Open: 19.0400 Day's Range: 18.7300 - 19.4700 Volume: 187,117
Previous Close: 19.0000 52wk Range: 15.5100 - 40.9800 1-Yr Rtn: -17.06%

Stock Chart for EPZM

No chart data available.
  • EPZM:US 19.1000
  • 1D
  • 1M
  • 1Y
19.0000
Interactive EPZM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EPZM

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.1700
Est. EPS (USD) (12/2015) -4.1310
Est. PEG Ratio -
Market Cap (M USD) 787.01
Shares Outstanding (M) 41.20
30 Day Average Volume 282,861
Price/Book (mrq) 3.5412
Price/Sale (ttm) 22.2832
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EPZM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EPZM

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers, and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

Peter HoChief Development OfficerRobert A CopelandPres:Research/Chief Scientific Ofcr
Andrew E SingerExec VP:Finance/CFO/TreasurerManisha PaiInvestor Relations
More Company Profile & Key Executives for EPZM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil